Tardive dyskinesia causes involuntary movements in some people taking antipsychotic medications. Here’s what you need to know about this movement disorder. Antipsychotic medications are a mainstay of ...

Tardive dyskinesia is not typically reversible, but on rare occasions, it can be if caught early and treated immediately. Tardive dyskinesia (TD) is a medication-induced movement disorder involving ...

—These investigators examined more than 2 decades’ worth of de-identified electronic health records to learn more about why tardive dyskinesia is likely to be underreported and misdiagnosed in routine ...

Some studies suggest vitamin E may help ease symptoms of tardive dyskinesia — but how strong is the evidence, and what does it really tell us? Note: The U.S. Food and Drug Administration (FDA) does ...

Tardive dyskinesia is a disorder causing uncontrolled movements in the face and body that can be a side effect of prescription drugs including antipsychotics, antidepressants, and more. Tardive ...

Credit: Getty Images This patient fact sheet describes the medications that are known to induce tardive dyskinesia, its symptoms, and ways in which the disease state may be managed. Our easy-to-read ...

Editor’s note: This is an automatically generated transcript, which has been slightly edited for clarity. Please notify [email protected] if there are concerns regarding accuracy of the transcription ...

Editor’s note: This is a previously posted video, and the below is an automatically generated transcript to be used for informational purposes. Please notify [email protected] if there are concerns ...

This was a prospective cohort study examining the incidence rate of tardive dyskinesia (TD) among 352 outpatients receiving atypical and/or typical antipsychotic medications at a community mental ...

—The exact pathology of tardive dyskinesia is still unclear, but the potential genetic factors these investigators have identified may enhance the understanding, treatment, and prevention of this ...

This football season, Teva is increasing education around tardive dyskinesia (TD) by launching ‘The Other TD’ campaign TD is a chronic movement ...

New draft guidelines on the definition of new active substances don’t apply to deutetrabenazine, the European drug regulator ...